GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ERK2 in complex with (S)-2-((9H-purin-6-yl) amino)-3-phenylpropan-1-ol

Analyse Crystal structure of ERK2 in complex with (S)-2-((9H-purin-6-yl)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4QP3
Type
protein
Length
672 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 1
EC
2.7.11.24
UniProt
P28482
Ligands
36Q
Pockets
12 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 36% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 1 (EC 2.7.11.24)protein34037% helix, 14% strandP28482
BMitogen-activated protein kinase 1 (EC 2.7.11.24)protein33234% helix, 14% strandP28482

Ligands and binding sites

  • 36Q · (2S)-3-phenyl-2-(9H-purin-6-ylamino)propan-1-ol · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111250.800.8212336Q
23240.640.803736Q
31070.630.8822empty
42510.560.7739empty
51030.400.7620empty

Interfaces

1 interface between chains.

  • A–B · 821 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 4QP3 · Crystal Structure of ERK2 in complex with (S)-2-((9H-purin-6-yl)amino)-3-phenylpropan-1-ol · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.